⚕️ FREE MSRA PODCAST – Restless Legs Syndrome
🎧 A clear, high-yield breakdown of this dopamine-linked neurological movement disorder – perfect for exam prep and real-life clinical scenarios.

🧠 Key Learning Points

📌 Definition
• A neurological disorder marked by an irresistible urge to move the legs
• Often accompanied by uncomfortable sensations (e.g., tingling, crawling, aching)
• Symptoms worsen during rest, especially at night, and are relieved by movement

📌 Causes & Risk Factors
• Primary (idiopathic) – likely genetic, linked to dopaminergic dysfunction
• Secondary causes include:
– Iron deficiency, pregnancy, chronic kidney disease, diabetes
– Deficiencies: B12, folate, magnesium
– Medications: antipsychotics, antidepressants
– Lifestyle factors: caffeine, alcohol, smoking, sleep deprivation
💡 Mnemonic: “I’M DR PREGG” – Iron, Meds, Deficiencies, Renal, Pregnancy, etc.

📌 Pathophysiology
• Dopamine dysfunction and iron dysregulation disrupt motor and sensory brain circuits
• Leads to misfiring signals → movement urge + sensory discomfort
• Fundamentally a brain-based disorder with limb symptoms

📌 Symptoms
• Urge to move legs, with tingling, pulling, crawling, or aching sensations
• Worse at rest or in the evening, relieved by movement
• Can progress to affect daytime and cause severe sleep disruption
💡 Mnemonic: “Worse when Resting, Less with Moving”

📌 Differential Diagnosis
• Peripheral neuropathy, akathisia, nocturnal leg cramps
• PAD – worse with exertion (opposite of RLS)
• Parkinsonism, venous insufficiency, myalgia, ADHD in children
• Key differentiators: pattern, timing, and movement response

📌 Diagnosis
• Clinical diagnosis – based on history + physical exam
• Fulfils IRLSSG 2014 Criteria:
– Urge + unpleasant sensations
– Worse at rest
– Better with movement
– Worse at night
– Not explained by another condition
• Supportive: good dopamine agonist response, family history, PLMD

📌 Management
• Stepwise approach:
– Lifestyle changes: exercise, reduce caffeine/alcohol, warm baths, sleep hygiene
– Treat underlying causes: especially iron deficiency
– Medications (if persistent):
• First-line: non-ergot dopamine agonists – pramipexole, ropinirole, rotigotine
• Others: gabapentin, pregabalin (pain-related RLS)
• Last-line: opioids, benzos, Z-drugs (short-term only)
• Beware of augmentation – paradoxical worsening from long-term dopamine agonist use
• Refer to neurology/sleep specialist if refractory, augmented, or paediatric case

📌 Complications
• Sleep disturbance, chronic insomnia
• Daytime fatigue, reduced quality of life
• Increased risk of anxiety and mental health impacts
• Potential augmentation or drug dependence from mismanagement

📌 Prognosis
• Often chronic but variable – may fluctuate or remit
• Secondary RLS can resolve completely if underlying issue corrected
• Symptoms manageable with appropriate lifestyle and medication support

📎 More MSRA Resources for Restless Legs Syndrome
📝 Revision Notes: https://www.passthemsra.com/topic/restless-legs-syndrome-revision-notes/
🧠 Flashcards: https://www.passthemsra.com/topic/restless-legs-syndrome-flashcards/
💬 Accordion Q&A Notes: https://www.passthemsra.com/topic/restless-legs-syndrome-accordion-qa-notes/
🚀 Rapid Quiz: https://www.passthemsra.com/topic/restless-legs-syndrome-rapid-quiz/
🧪 Quiz Bank: https://www.passthemsra.com/quizzes/restless-legs-syndrome/
🎓 Full Course: https://www.passthemsra.com/courses/neurology-for-the-msra/

Hashtags
#MSRA #MSRARevision #MSRATextbook #MSRAQuiz #MSRAQuestionBank #MSRAFlashcards #MSRAQANotes #MSRAAccordions #MSRAOnlineRevision #MultiSpecialityRecruitmentAssessment #RestlessLegsSyndrome #NeurologyForMSRA #RLS #IronDeficiency #SleepDisorder

🎧 FREE MSRA PODCAST – Psychogenic Non-Epileptic Seizures (PNES): Mastering the Mimicry

Struggling to distinguish between epileptic and non-epileptic seizures? This Deep Dive covers PNES, a high-yield exam topic and an essential real-life diagnostic challenge. We’ll walk through classic clues, key differentiators, and the must-know management for the MSRA.

📝 Key Learning Points

📌 Definition
• PNES are episodes that look like epileptic seizures but are NOT caused by abnormal electrical activity in the brain.
• They are functional neurological symptoms, often arising from psychological distress (a form of conversion disorder).
• Also called Non-Epileptic Attack Disorder (NEAD).

📌 Core Features
• Shaking, unresponsiveness, convulsions—just like epilepsy
• But: No EEG changes during the event

📌 Key Differentiators (from Epilepsy)
• Gradual onset, longer duration, waxing/waning intensity
• Pelvic thrusting, side-to-side head movement, eyes tightly shut
• Recollection of events during apparent unresponsiveness
• Often triggered by stress, rarely occurs when alone
• Crying post-event, absence of post-ictal confusion
• Classic epilepsy signs: Side tongue-biting, automatisms, and raised serum prolactin point to epilepsy, but not 100% reliable

📌 Causes & Risk Factors
• Psychological trauma (e.g. abuse, PTSD)
• High stress, emotional conflict
• Coexisting psychiatric disorders: anxiety, depression, personality disorders
• Female predominance, often in young adults
• History of epilepsy or family members with epilepsy
• NB: PNES is involuntary—never consciously faked

📌 Differential Diagnosis
• Epilepsy (generalised/focal)
• Syncope, cardiac arrhythmia, hypoglycaemia, migraine, TIA
• Panic attacks, dissociative disorders, factitious disorder, movement disorders, sleep disorders

📌 Epidemiology
• 15–20% of referrals to epilepsy clinics; up to 40% in epilepsy monitoring units
• More common in women, but can affect all ages and backgrounds

📌 Diagnosis
• Gold standard: Video EEG monitoring (seizure-like activity with no EEG change)
• Multidisciplinary assessment: Detailed clinical history, psychiatric evaluation
• Rule out metabolic, cardiac, neurological causes
• Serum prolactin NOT reliable for diagnosis

📌 Management
• Psychological therapy is KEY – especially cognitive behavioural therapy (CBT)
• Antiepileptic drugs are not effective and may be harmful
• Treat underlying psychiatric conditions (anxiety, depression, PTSD)
• Multidisciplinary care: neurologist + psychiatry/psychology
• Patient & family education/support
• Early referral to psychological services is essential for best outcomes

📌 Prognosis & Complications
• Prognosis improves with early recognition, diagnosis, and engagement with therapy
• Untreated: persistent disability, reduced quality of life, continued distress, unnecessary drug side effects
• Delayed/missed diagnosis = years of ineffective treatment
• Comorbid psychiatric issues can complicate recovery

📎 More MSRA PNES Resources:
📝 Revision Notes: https://www.passthemsra.com/topic/psychogenic-non-epileptic-seizures-revision-notes/
🧠 Flashcards: https://www.passthemsra.com/topic/psychogenic-non-epileptic-seizures-flashcards/
💬 Accordion Q&A: https://www.passthemsra.com/topic/psychogenic-non-epileptic-seizures-accordion-qa-notes/
🚀 Rapid Quiz: https://www.passthemsra.com/topic/psychogenic-non-epileptic-seizures-rapid-quiz/
🧪 Quiz Bank: https://www.passthemsra.com/quizzes/psychogenic-non-epileptic-seizures/
🎓 Neurology MSRA Course: https://www.passthemsra.com/courses/neurology-for-the-msra/

#MSRA #PNES #PsychogenicNonEpilepticSeizures #MSRARevision #MSRAFlashcards #MSRAQuiz #MSRAAccordions #Neurology #EpilepsyMimics #ConversionDisorder #PassTheMSRA

⚕️ FREE MSRA PODCAST – Parkinson’s Disease
🎧 A clear, high-yield breakdown of this progressive movement disorder – perfect for exam prep and real-life clinical scenarios.

🧠 Key Learning Points

📌 Definition
• Chronic, progressive neurodegenerative condition affecting movement.
• Caused by dopamine neuron loss in the substantia nigra.

📌 Causes & Risk Factors
• Largely idiopathic (unknown cause)
• Genetic mutations (e.g. LRRK2, GBA)
• Environmental toxins (e.g. pesticides)
• Age (risk ↑ with age)
• Male sex (2:1 ratio)
🧠 Mnemonic: "GEM-Age" = Genetics, Environment, Male, Age

📌 Pathophysiology
• Dopamine-producing neurons degenerate in substantia nigra
• ↓ Dopamine → dysfunction in basal ganglia motor circuits
• Leads to motor control issues

📌 Symptoms
• Motor: Tremor (resting), Rigidity, Akinesia/Bradykinesia, Postural Instability
• Non-motor: Hyposmia, constipation, REM sleep disorder, depression, cognitive decline
🧠 Mnemonic: TRAP = Tremor, Rigidity, Akinesia, Postural instability

📌 Differential Diagnosis
• Essential tremor
• Drug-induced Parkinsonism
• Progressive supranuclear palsy
• Multiple system atrophy
• Lewy body dementia

📌 Diagnosis
• Clinical diagnosis: bradykinesia + 1 other TRAP feature
• DAT scan (SPECT): ↓ dopamine uptake
• MRI: To rule out mimics
🧠 Tip: DAT scan helps differentiate from essential tremor

📌 Management
• Levodopa (gold standard)
• Dopamine agonists (e.g. ropinirole)
• MAO-B inhibitors (e.g. selegiline)
• COMT inhibitors, amantadine, anticholinergics
• Advanced options: Apomorphine pump, Duodopa, Deep Brain Stimulation (DBS)
• MDT input: physio, OT, SLT, PD nurse
🧠 NICE: Offer levodopa if motor symptoms affect life

📌 Complications
• Motor fluctuations, dyskinesias
• Falls, aspiration pneumonia
• Dementia, hallucinations
• Parkinson’s crisis (acute akinesia)
• Autonomic dysfunction (hypotension, constipation)

📌 Prognosis
• Variable but progressive
• Life expectancy may be slightly reduced
• Quality of life can be maintained for many years with good MDT care

📎 More MSRA Resources for Parkinson’s Disease
📝 Revision Notes: https://www.passthemsra.com/topic/parkinsons-disease-revision-notes/
🧠 Flashcards: https://www.passthemsra.com/topic/parkinsons-disease-flashcards/
💬 Accordion Q&A Notes: https://www.passthemsra.com/topic/parkinsons-disease-accordion-qa-notes/
🚀 Rapid Quiz: https://www.passthemsra.com/topic/parkinsons-disease-rapid-quiz/
🎓 Full Course: https://www.passthemsra.com/courses/neurology-for-the-msra/

Hashtags
#MSRA #MSRARevision #MSRATextbook #MSRAQuiz #MSRAQuestionBank #MSRAFlashcards #MSRAQ&ANotes #MSRAAccordions #MultiSpecialityRecruitmentAssessment #MSRAOnlineRevision #MSRARevisionWebsite #ParkinsonsDisease

🎧🧠 MSRA DEEP DIVE: Parkinsonism — High-Yield Revision Breakdown

Today, we’re cutting through the complexity of Parkinsonism — a term that often confuses candidates — and breaking it into crystal-clear, exam-ready knowledge for your MSRA. Let’s get straight into your notes 🔬

🔑 Core Revision Summary

📌 Definition
• Parkinsonism = umbrella term for motor symptoms:
Tremor (resting),
Rigidity,
Bradykinesia,
Postural instability
• Idiopathic Parkinson’s Disease (PD) = most common subtype

📌 Causes
• Idiopathic PD (most common)
• Drug-induced: antipsychotics, metoclopramide (Domperidone safer)
• Vascular Parkinsonism
• Atypical Parkinsonian syndromes:

• Multiple System Atrophy (MSA)

• Progressive Supranuclear Palsy (PSP)

• Corticobasal Degeneration (CBD)
  • Rarer: Wilson’s disease, toxins (CO, MPTP), post-encephalitic, trauma

📌 Pathophysiology
• PD: Loss of dopamine neurons in substantia nigra
• Others: vascular injury, protein accumulation (atypical syndromes), toxins

📌 Risk Factors
• Age (strongest factor across subtypes)
• Medications (antipsychotics, antiemetics)
• Genetics (esp. for atypical syndromes)

📌 Differential Diagnosis
• Key: Distinguish idiopathic PD vs atypical vs vascular vs drug-induced
• Use detailed history, exam & red flags (e.g. early autonomic dysfunction, cerebellar signs, cognitive decline)

📌 Diagnosis
• Clinical criteria: UK Parkinson's Disease Society Brain Bank / MDS Criteria
• Imaging: MRI/CT (exclude structural causes), DAT scan (dopaminergic deficit)
• Bloods: Wilson’s, metabolic causes
• Genetic tests: selected cases

📌 Epidemiology
• Idiopathic PD: ~1 in 350 adults >40y (UK)
• Prevalence rises with age
• Atypical syndromes = much rarer

📌 Clinical Features
• TRBP core +:

• Shuffling gait

• Reduced arm swing

• Masked facies

• Micrographia
  • Red flags: early falls, postural hypotension, cerebellar signs, rapid cognitive decline

📌 Management
🎯 Idiopathic PD:
• Levodopa
• Dopamine agonists
• MAO-B inhibitors
• Multidisciplinary rehab: physio, OT, speech therapy, mental health support
🎯 Atypical/Vascular Parkinsonism:
• Limited dopamine response → focus on supportive care
🎯 Drug-induced:
• Withdraw causative agent

📌 Prognosis
• Idiopathic PD: progressive but highly variable; good function possible for years with treatment
• Atypical Parkinsonism: more rapid decline, poorer prognosis
• Drug-induced: often reversible

📌 Complications
• Motor: fluctuations, dyskinesia
• Non-motor: dementia, depression, autonomic dysfunction, falls, sleep disorders

📚 Extra MSRA Revision Resources

📝 Revision Notes:
https://www.passthemsra.com/topic/parkinsonism-revision-notes/
🧠 Flashcards:
https://www.passthemsra.com/topic/parkinsonism-flashcards/
💬 Accordion Q&A:
https://www.passthemsra.com/topic/parkinsonism-accordion-qa-notes/
🚀 Rapid Quiz:
https://www.passthemsra.com/topic/parkinsonism-rapid-quiz/
🧪 MSRA Quiz Bank:
https://www.passthemsra.com/quizzes/parkinsonism/
🎓 MSRA Neurology Course:
https://www.passthemsra.com/courses/neurology-for-the-msra/

#MSRA #MSRARevision #Parkinsonism #NeurologyMSRA #MSRAFlashcards #MSRAQuiz #MSRAQANotes #HighYieldMSRA #NeurologyRevision #PassTheMSRA

⚕️ FREE MSRA PODCAST – Peripheral Neuropathy

🎧 A high-yield breakdown of this common nerve disorder causing weakness, tingling, or pain – perfect for acing your exams and boosting clinical insight!

🧠 Key Learning Points

📌 Definition
• Damage or dysfunction of peripheral nerves outside the brain and spinal cord
• Often affects hands and feet in a "glove and stocking" pattern

📌 Causes & Risk Factors
• 🔶 Diabetes mellitus (most common)
• 🔶 Vitamin B12 deficiency, alcohol misuse, chemotherapy
• 🔶 Infections (e.g., HIV, Lyme disease)
• 🔶 Autoimmune conditions (e.g., Guillain-Barré)
• 🔶 Genetics, trauma, or nerve compression
💡 Mnemonic: DANG THERAPY (Diabetes, Alcohol, Nutrition, Guillain-Barré, Trauma, Hereditary, etc.)

📌 Pathophysiology
• 🔹 Axonal degeneration
• 🔹 Demyelination of nerves
• 🔹 Impaired blood supply (especially in diabetes)
• Leads to impaired signal conduction

📌 Symptoms
• Tingling, numbness, burning pain
• Weakness or clumsiness
• Loss of vibration/proprioception
💡 Think: “Numb toes, clumsy steps!”

📌 Differential Diagnosis
• Radiculopathy
• Myopathy
• Central nervous system disorders (e.g., MS)

📌 Diagnosis
• 🧪 Bloods (B12, glucose, thyroid, autoimmune screen)
• ⚡ Nerve conduction studies (NCS), EMG
• 🧠 MRI or lumbar puncture if indicated
💡 Use tests to rule out mimics & assess severity

📌 Management
• ✅ Treat underlying cause (e.g., control diabetes)
• ✅ Pain relief: gabapentin, amitriptyline, duloxetine
• ✅ Physiotherapy & occupational therapy
• ✅ Multidisciplinary care
• ✅ Lifestyle: avoid alcohol, improve nutrition

📌 Complications
• Chronic pain
• Foot ulcers, infections, amputations (esp. in diabetics)
• Falls from poor balance

📌 Prognosis
• Variable – often stable or slowly progressive
• Can improve if cause is reversible
• Early treatment = better outcomes

📎 More MSRA Resources for Peripheral Neuropathy

📝 Revision Notes
https://www.passthemsra.com/topic/peripheral-neuropathy-revision-notes/

🧠 Flashcards
https://www.passthemsra.com/topic/peripheral-neuropathy-flashcards/

💬 Accordion Q&A Notes
https://www.passthemsra.com/topic/peripheral-neuropathy-accordion-qa-notes/

🚀 Rapid Quiz
https://www.passthemsra.com/topic/peripheral-neuropathy-rapid-quiz/

🎓 Full Course
https://www.passthemsra.com/courses/neurology-for-the-msra/

#MSRA #MSRARevision #MSRATextbook #MSRAQuiz #MSRAQuestionBank #MSRAFlashcards #MSRAQANotes #MSRAAccordions #MultiSpecialityRecruitmentAssessment #MSRAOnlineRevision #MSRARevisionWebsite #PeripheralNeuropathy #Neurology

🎧 FREE MSRA PODCAST – Neuropathic Pain: High-Yield Recognition & Management Essentials

Struggling to get your head around neuropathic pain? In this Deep Dive, we strip it back to the must-know facts for the MSRA: core definitions, classic symptoms, and what NICE actually recommends for treatment.

📝 Key Learning Points

📌 Definition
• Chronic pain originating from damage or dysfunction within the nervous system
• IASP: “Pain caused by a lesion or disease of the somatosensory system”

📌 Typical Descriptions
• Burning, electric shock, shooting, stabbing, tingling, numbness
• Look for words like “pins & needles”, “shooting pain”, “allodynia” (pain from light touch)

📌 Common Causes
• Peripheral: Diabetic neuropathy, postherpetic neuralgia, trigeminal neuralgia, radiculopathy, alcohol neuropathy, trauma
• Central: Post-stroke pain, multiple sclerosis, spinal cord injury
• Chemotherapy (can be both)

📌 Risk Factors
• Diabetes, trauma, infections (e.g. shingles), autoimmune diseases, neurotoxic drugs (e.g. chemo), older age

📌 Pathophysiology
• Nerves become hyper-excitable
• Abnormal pain signalling & altered pain processing in both peripheral and central nervous systems
• Maladaptive rewiring leads to chronicity

📌 Key Clinical Features
• Pain quality: Burning, shooting, tingling, electric
• Sensory changes: Allodynia, hyperalgesia, paraesthesia
• Distribution: Often follows nerve/root pattern
• Functional impact: Sleep, mood, daily life often impaired

📌 Differential Diagnosis
• Nociceptive pain (tissue injury: ache/throb)
• Musculoskeletal pain (joints, muscle)
• Psychogenic pain (psychological drivers)
• Red flags: Always clarify quality & triggers!

📌 Epidemiology
• Affects 7–10% of UK adults
• More common with age and in chronic conditions (e.g. diabetes: 16–26% have painful neuropathy)

📌 Investigation
• History + neuro exam (pain description is key!)
• Nerve conduction studies, MRI for compression/structural causes
• Bloods for diabetes, B12, thyroid if relevant

📌 Management (NICE CG173, 2013)
First-line (except trigeminal neuralgia):
1️⃣ Amitriptyline
2️⃣ Duloxetine
3️⃣ Gabapentin
4️⃣ Pregabalin
→ Try sequentially; switch if not tolerated/effective
• Rescue: Short-term tramadol for acute flares
• Localised: Topical capsaicin cream
• Non-drug: CBT, physio, pain team referral for resistant cases

⚠️ Avoid starting (unless pain specialist involved):
Cannabis extract, high-strength capsaicin patches, lacosamide, lamotrigine, oxcarbazepine, tapiramate, long-term tramadol, venlafaxine, morphine/strong opioids

📌 Prognosis & Complications
• Variable: Some resolve, many are chronic
• Key impact: Reduced quality of life, sleep disturbance, depression/anxiety, disability
• Multidisciplinary care is essential

📎 More MSRA Neuropathic Pain Resources:
📝 Revision Notes: https://www.passthemsra.com/topic/neuropathic-pain-revision-notes/
🧠 Flashcards: https://www.passthemsra.com/topic/neuropathic-pain-flashcards/
💬 Accordion Q&A: https://www.passthemsra.com/topic/neuropathic-pain-accordion-qa-notes/
🚀 Rapid Quiz: https://www.passthemsra.com/topic/neuropathic-pain-rapid-quiz/
🧪 Quiz Bank: https://www.passthemsra.com/quizzes/neuropathic-pain/
🎓 Neurology MSRA Course: https://www.passthemsra.com/courses/neurology-for-the-msra/

#MSRA #NeuropathicPain #MSRARevision #MSRAFlashcards #MSRAQuiz #MSRAAccordions #Neurology #ChronicPain #PassTheMSRA

⚕️ FREE MSRA PODCAST – Normal Pressure Hydrocephalus (NPH)
🎧 A clear, high-yield breakdown of this reversible cause of dementia with classic triad – perfect for exam prep and real-life clinical scenarios.

🧠 Key Learning Points

📌 Definition
• A neurological disorder involving ventricular enlargement due to impaired CSF absorption, but with normal average pressure
• Causes the classic triad: gait disturbance, cognitive decline, and urinary incontinence

📌 Causes & Risk Factors
• Idiopathic NPH – most common, seen in older adults
• Secondary NPH – due to:
– Subarachnoid haemorrhage
– Meningitis
– Head injury
– Brain tumours
• Risk factors: Age >60, prior brain surgery, trauma, infection
💡 Mnemonic: “Worn PATH” – Women/Men equally, Over 60, Radiation/surgery, Neuro infections, Post-SAH, Ageing, Trauma, Head injury

📌 Pathophysiology
• CSF absorption is reduced (not overproduced), leading to ventricular dilation
• Pressure on nearby brain tissue disrupts gait, cognition, and bladder control

📌 Symptoms
• Gait disturbance – slow, wide-based, shuffling (first to appear)
• Urinary symptoms – urgency → incontinence
• Cognitive decline – executive dysfunction, bradyphrenia, disorientation
💡 Mnemonic: “Wet, Wobbly, Wacky”

📌 Differential Diagnosis
• Alzheimer’s disease
• Parkinson’s disease
• Vascular dementia
• Frontotemporal dementia
• Multiple system atrophy

📌 Diagnosis
• MRI or CT – shows ventriculomegaly, possibly DESH pattern
• CSF Tap Test – temporary symptom improvement after lumbar puncture
• ICP monitoring, lumbar infusion tests for unclear cases
💡 Tip: No papilloedema helps distinguish from raised ICP hydrocephalus

📌 Management
• Ventriculoperitoneal (VP) shunt – definitive treatment
• Alternative: ventriculoatrial shunt
• Rehabilitation post-op is crucial (gait training, physio)
• Medical options (e.g. acetazolamide) have limited benefit
• Repeated LP – temporary relief only
🎯 Early diagnosis → better prognosis

📌 Complications
• Shunt malfunction or blockage
• Infection
• Overdrainage → subdural haematomas, low-pressure headaches
• Underdrainage, catheter migration, general surgery risks

📌 Prognosis
• 80–90% show improvement post-shunting
• Best outcomes if treated early (within 3 months of symptom onset)
• Gait often improves most; cognitive and bladder function may also recover
• ~6% risk of long-term complications, ~22% may need revision surgery

📎 More MSRA Resources for Normal Pressure Hydrocephalus
📝 Revision Notes: https://www.passthemsra.com/topic/normal-pressure-hydrocephalus-revision-notes/
🧠 Flashcards: https://www.passthemsra.com/topic/normal-pressure-hydrocephalus-flashcards/
💬 Accordion Q&A Notes: https://www.passthemsra.com/topic/normal-pressure-hydrocephalus-accordion-qa-notes/
🚀 Rapid Quiz: https://www.passthemsra.com/topic/normal-pressure-hydrocephalus-rapid-quiz/
🧪 Quiz Bank: https://www.passthemsra.com/quizzes/normal-pressure-hydrocephalus/
🎓 Full Course: https://www.passthemsra.com/courses/neurology-for-the-msra/

Hashtags
#MSRA #MSRARevision #MSRATextbook #MSRAQuiz #MSRAQuestionBank #MSRAFlashcards #MSRAQANotes #MSRAAccordions #MSRAOnlineRevision #MultiSpecialityRecruitmentAssessment #NormalPressureHydrocephalus #NPH #NeurologyMSRA #WetWobblyWacky #ReversibleDementia

⚕️ FREE MSRA PODCAST – Neuroleptic Malignant Syndrome (NMS)
🎧 A clear, high-yield breakdown of this life-threatening antipsychotic reaction – perfect for exam prep and real-life clinical scenarios.

🧠 Key Learning Points

📌 Definition
• A rare but potentially fatal reaction to dopamine antagonist drugs, especially antipsychotics.
• Characterised by ⬆️ temperature, 🤕 rigidity, 🤯 altered mental state, and 🔄 autonomic dysfunction.

📌 Causes & Risk Factors
• Triggered by antipsychotics (e.g. haloperidol, risperidone)
• Sudden withdrawal of dopaminergic meds (e.g. levodopa)
• High doses, depot preparations 💉
• Rapid dose escalation
• 🌞 Hot environment, dehydration
• ♂️ Male sex, agitation, prior NMS episode

📌 Pathophysiology
• Dopamine blockade in CNS → disrupts thermoregulation & motor control
• Muscle rigidity → rhabdomyolysis 💔
• ⬆️ CK, metabolic acidosis
• May involve ↑ glutamate toxicity

📌 Symptoms
• Fever 🌡️
• Lead-pipe rigidity 🤕
• Confusion, agitation
• Autonomic instability: tachycardia, BP swings, sweating
• Tremor, breathing difficulties
🧠 Mnemonic: "FARM" – Fever, Autonomic, Rigidity, Mental status change

📌 Differential Diagnosis
• Serotonin syndrome
• Malignant hyperthermia
• Heat stroke 🥵
• Anticholinergic toxicity
• Sepsis, encephalitis
• Catatonia, overdose
🧠 Tip: NMS often lacks clonus (vs serotonin syndrome) and persists despite anticholinergics

📌 Diagnosis
• Clinical diagnosis 📋
• Criteria: recent dopamine antagonist use + ⬆️ temp + rigidity + ≥5 supportive features
• Features: ↑ CK, tachycardia, unstable BP, leukocytosis, tremor, acidosis, incontinence
• Rule out mimics with labs, CT, LP

📌 Management
• 🚫 Stop causative drug
• 🏥 Admit, often ICU
• IV fluids, active cooling
• Benzodiazepines for agitation 😴
• Dantrolene (muscle relaxant) or bromocriptine (dopamine agonist) may be used
• Consider dialysis if rhabdo severe
• Avoid physical restraint

📌 Complications
• Rhabdomyolysis → acute kidney injury
• Respiratory failure
• DIC, seizures, arrhythmias
• Pulmonary embolism, pneumonitis

📌 Prognosis
• Good with early treatment ⏱️
• Mortality 5–11.6% if missed
• Poorer outcomes if elderly, delayed treatment, severe fever, or comorbidities

📎 More MSRA Resources for Neuroleptic Malignant Syndrome
📝 Revision Notes: https://www.passthemsra.com/topic/neuroleptic-malignant-syndrome-revision-notes/
🧠 Flashcards: https://www.passthemsra.com/topic/neuroleptic-malignant-syndrome-flashcards/
💬 Accordion Q&A Notes: https://www.passthemsra.com/topic/neuroleptic-malignant-syndrome-accordion-qa-notes/
🚀 Rapid Quiz: https://www.passthemsra.com/topic/neuroleptic-malignant-syndrome-rapid-quiz/
🎓 Full Course: https://www.passthemsra.com/courses/neurology-for-the-msra/

Hashtags
#MSRA #MSRARevision #MSRATextbook #MSRAQuiz #MSRAQuestionBank #MSRAFlashcards #MSRAQANotes #MSRAAccordions #MultiSpecialityRecruitmentAssessment #MSRAOnlineRevision #MSRARevisionWebsite #NeurolepticMalignantSyndrome

🎧 FREE MSRA PODCAST – Myasthenia Gravis: Autoimmunity, Fluctuating Weakness, and Exam Essentials

In this Deep Dive, we demystify Myasthenia Gravis — a classic exam favourite and must-know for MSRA Neurology. Listen for everything you need to recognise, diagnose, and manage MG with confidence.

📝 Key Learning Points

📌 Definition
• Chronic autoimmune disorder affecting the neuromuscular junction
• Characterised by fluctuating, fatigable muscle weakness — especially affecting eyes, face, swallowing, and sometimes breathing

📌 Pathology & Causes
• Autoimmune attack: Most commonly IgG1 autoantibodies target the acetylcholine receptor (AChR) on the muscle side of the neuromuscular junction
• Less commonly, antibodies against MuSK protein
• Strong association with thymus gland abnormalities (thymoma in 15%, hyperplasia in up to 70%)
• Linked to other autoimmune diseases (Graves, SLE, RA, vitiligo, Addison’s)

📌 Epidemiology & Risk Factors
• Prevalence: 15–20 per 100,000 in the UK
• Bimodal onset: younger women (20s–30s), older men (>60)
• Increased risk with family history, specific HLA types (B8, DR3), and coexisting autoimmune conditions

📌 Clinical Features
• Cardinal feature: muscle weakness that worsens with activity and improves with rest
• Ocular (ptosis, diplopia), bulbar (dysarthria, dysphagia), and generalised (proximal limb) weakness
• Respiratory muscle weakness = myasthenic crisis (emergency)
• Triggers: infection, stress, certain drugs (aminoglycosides, fluoroquinolones, beta blockers, etc.)

📌 Diagnosis
• Bedside clues: Fluctuating, fatigable weakness without sensory loss
• Antibody tests: AChR and MuSK antibodies (AChR+ in ~90% of generalised cases)
• Neurophysiology: Repetitive nerve stimulation (decremental response); single-fibre EMG (increased jitter)
• Imaging: Chest CT/MRI to look for thymoma
• Ice pack test for ptosis (improvement after cooling)
• Avoid edrophonium (Tensilon) test due to risks

📌 Management
• First line: Acetylcholinesterase inhibitors (pyridostigmine)
• Immunosuppression: Corticosteroids, azathioprine (steroid-sparing), sometimes other agents (mycophenolate, rituximab)
• Thymectomy: If thymoma or generalised AChR+ MG, especially in younger patients
• Acute exacerbations/myasthenic crisis: IVIG or plasmapheresis, plus respiratory support
• Multidisciplinary care: Speech therapy, physio, OT, dietary support

📌 Prognosis & Complications
• Outlook is good for most with modern treatments — near-normal life expectancy
• Risks: myasthenic crisis (respiratory failure, requires ventilation), long-term immunosuppression complications, residual weakness
• Watch for associated autoimmune diseases

📎 More MSRA Myasthenia Gravis Resources:
📝 Revision Notes: https://www.passthemsra.com/topic/myasthenia-gravis-revision-notes/
🧠 Flashcards: https://www.passthemsra.com/topic/myasthenia-gravis-flashcards/
💬 Accordion Q&A: https://www.passthemsra.com/topic/myasthenia-gravis-accordion-qa-notes/
🚀 Rapid Quiz: https://www.passthemsra.com/topic/myasthenia-gravis-rapid-quiz/
🧪 Quiz Bank: https://www.passthemsra.com/quizzes/myasthenia-gravis/
🎓 Neurology MSRA Course: https://www.passthemsra.com/courses/neurology-for-the-msra/

#MSRA #MyastheniaGravis #MSRARevision #Neurology #MSRAFlashcards #MSRAQuiz #MSRAAccordions #Autoimmunity #PassTheMSRA

🎧🧬 MSRA DEEP DIVE: Neurofibromatosis (NF1, NF2 & Schwannomatosis) — High-Yield Revision

Today we break down one of the most exam-tested neurogenetic disorders for MSRA — Neurofibromatosis (NF) 🔬

🔑 Core Revision Summary

📌 Definition
• Genetic disorder causing nerve tumors 🧠
• 3 types: NF1 (von Recklinghausen’s), NF2, Schwannomatosis
• Key: tumor suppressor gene mutations

📌 Genetics & Pathophysiology
• NF1: NF1 gene (chromosome 17q11.2) → neurofibromin dysfunction
• NF2: NF2 gene (chromosome 22) → merlin dysfunction
• Autosomal dominant inheritance (50% chance)
• ~50% de novo mutations in both NF1 & NF2
• 100% penetrance (NF1), variable expressivity

📌 Epidemiology
• NF1: ~1 in 3000 births (96% of NF cases)
• NF2: ~1 in 33,000 births
• No gender or ethnic bias

📌 NF1 Key Features
• ≥6 Café-au-lait spots (size-dependent on age)
• Axillary/inguinal freckling
• ≥2 neurofibromas or 1 plexiform neurofibroma
• Optic gliomas
• ≥2 Lisch nodules (iris)
• Bony lesions (sphenoid dysplasia, pseudoarthrosis)
• 1st degree affected relative

📌 NF2 Key Features
• Bilateral vestibular schwannomas (hallmark 🎧)
• Hearing loss, tinnitus, balance issues
• Meningiomas, ependymomas, spinal tumors
• Juvenile cataracts
• Family history + unilateral schwannoma or multiple other lesions

📌 Schwannomatosis
• Multiple schwannomas excluding vestibular nerve
• Chronic severe pain main feature

📌 Complications
• NF1: Malignant peripheral nerve sheath tumor (MPNST) 🧨
• Optic glioma → vision loss
• Skeletal: scoliosis, pseudoarthrosis
• Pheochromocytoma → hypertension
• Learning difficulties, ADHD
• Psychological & cosmetic burden
• NF2: Brainstem compression, hearing loss, progressive disability

📌 Investigations
• Clinical diagnosis primary ✅
• Genetic testing: confirmatory but not first-line
• MRI: brain/spine tumors, optic glioma, hydrocephalus
• Ophthalmology: Lisch nodules (NF1), cataracts (NF2)
• Audiology: hearing tests (NF2)
• X-rays for skeletal issues

📌 Management
🎯 NF1
• Monitor neurofibromas (surgery if symptomatic)
• Plexiform: surgery, selumetinib (licensed for children)
• Manage learning, vision, skeletal & BP issues
🎯 NF2
• MRI monitoring, hearing preservation
• Surgery/radiation for vestibular schwannomas
• Bevacizumab (VEGF inhibitor) for tumor control
🎯 Schwannomatosis
• Pain control, selective schwannoma resection

📌 Prognosis
• NF1: Variable; many live full lives
• NF2: Worse prognosis; brainstem & hearing complications
• Early detection = better outcomes for both

📌 Genetic Counselling
• 50% inheritance risk
• Prenatal testing & PGD available
• Cannot predict severity if gene is passed

📚 Extra MSRA Revision Resources

📝 Revision Notes:
https://www.passthemsra.com/topic/neurofibromatosis-revision-notes/
🧠 Flashcards:
https://www.passthemsra.com/topic/neurofibromatosis-flashcards/
💬 Accordion Q&A:
https://www.passthemsra.com/topic/neurofibromatosis-accordion-qa-notes/
🚀 Rapid Quiz:
https://www.passthemsra.com/topic/neurofibromatosis-rapid-quiz/
🧪 MSRA Quiz Bank:
https://www.passthemsra.com/quizzes/neurofibromatosis/
🎓 MSRA Neurology Course:
https://www.passthemsra.com/courses/neurology-for-the-msra/

#MSRA #MSRARevisionNotes #MSRANeurofibromatosis #MSRAFlashcards #MSRAQANotes #MSRAQuiz #Neurology #NF1 #NF2 #Schwannomatosis #HighYieldMSRA